IL164018A0 - Certain 1-(d-cyclopropylglycinyl)-4-(piperidin-4-yl)piperazine compounds as inhibitors of the serineprotease factor xa - Google Patents

Certain 1-(d-cyclopropylglycinyl)-4-(piperidin-4-yl)piperazine compounds as inhibitors of the serineprotease factor xa

Info

Publication number
IL164018A0
IL164018A0 IL16401803A IL16401803A IL164018A0 IL 164018 A0 IL164018 A0 IL 164018A0 IL 16401803 A IL16401803 A IL 16401803A IL 16401803 A IL16401803 A IL 16401803A IL 164018 A0 IL164018 A0 IL 164018A0
Authority
IL
Israel
Prior art keywords
factor
inhibitors
cyclopropylglycinyl
serineprotease
piperidin
Prior art date
Application number
IL16401803A
Other languages
English (en)
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of IL164018A0 publication Critical patent/IL164018A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56—Nitrogen atoms
    • C07D211/58—Nitrogen atoms attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/44—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • C07C235/52—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/02—Systems containing only non-condensed rings with a three-membered ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IL16401803A 2002-04-01 2003-03-24 Certain 1-(d-cyclopropylglycinyl)-4-(piperidin-4-yl)piperazine compounds as inhibitors of the serineprotease factor xa IL164018A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US36852302P 2002-04-01 2002-04-01
PCT/US2003/007794 WO2003084929A1 (en) 2002-04-01 2003-03-24 Certain 1-(d-cyclopropylglycinyl)-4-(piperidin-4-yl)piperazine compounds as inhibitors of the serine protease factor xa

Publications (1)

Publication Number Publication Date
IL164018A0 true IL164018A0 (en) 2005-12-18

Family

ID=28791889

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16401803A IL164018A0 (en) 2002-04-01 2003-03-24 Certain 1-(d-cyclopropylglycinyl)-4-(piperidin-4-yl)piperazine compounds as inhibitors of the serineprotease factor xa

Country Status (24)

Country Link
US (1) US7166606B2 (cg-RX-API-DMAC7.html)
EP (1) EP1492767B1 (cg-RX-API-DMAC7.html)
JP (1) JP2005531529A (cg-RX-API-DMAC7.html)
KR (1) KR20040094892A (cg-RX-API-DMAC7.html)
CN (1) CN1288135C (cg-RX-API-DMAC7.html)
AT (1) ATE303990T1 (cg-RX-API-DMAC7.html)
AU (1) AU2003218147A1 (cg-RX-API-DMAC7.html)
BR (1) BR0308870A (cg-RX-API-DMAC7.html)
CA (1) CA2478340A1 (cg-RX-API-DMAC7.html)
CR (1) CR7497A (cg-RX-API-DMAC7.html)
DE (1) DE60301569T2 (cg-RX-API-DMAC7.html)
DK (1) DK1492767T3 (cg-RX-API-DMAC7.html)
EA (1) EA007300B1 (cg-RX-API-DMAC7.html)
EC (1) ECSP045329A (cg-RX-API-DMAC7.html)
ES (1) ES2248737T3 (cg-RX-API-DMAC7.html)
HR (1) HRP20040900B1 (cg-RX-API-DMAC7.html)
IL (1) IL164018A0 (cg-RX-API-DMAC7.html)
MX (1) MXPA04009640A (cg-RX-API-DMAC7.html)
NO (1) NO20044688L (cg-RX-API-DMAC7.html)
NZ (1) NZ535402A (cg-RX-API-DMAC7.html)
PL (1) PL373066A1 (cg-RX-API-DMAC7.html)
UA (1) UA76849C2 (cg-RX-API-DMAC7.html)
WO (1) WO2003084929A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA200407418B (cg-RX-API-DMAC7.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6834308B1 (en) 2000-02-17 2004-12-21 Audible Magic Corporation Method and apparatus for identifying media content presented on a media playing device
US7363278B2 (en) 2001-04-05 2008-04-22 Audible Magic Corporation Copyright detection and protection system and method
US8972481B2 (en) 2001-07-20 2015-03-03 Audible Magic, Inc. Playlist generation method and apparatus
DE102014108210A1 (de) 2014-06-11 2015-12-17 Dietrich Gulba Rodentizid
WO2018093716A1 (en) * 2016-11-18 2018-05-24 Merck Sharp & Dohme Corp. FACTOR XIIa INHIBITORS
EP4070658A1 (de) 2021-04-06 2022-10-12 BIORoxx GmbH Verwendung von blutgerinnungshemmenden verbindungen als rodentizide

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999011658A1 (en) 1997-08-29 1999-03-11 Proteus Molecular Design Ltd. Meta-benzamidine derivatives as serin protease inhibitors
CA2375920A1 (en) 1999-06-14 2000-12-21 Eli Lilly And Company Compounds
CA2383008A1 (en) 1999-06-14 2000-12-21 Amanda Jane Lyons Compounds
GB0030305D0 (en) 2000-12-13 2001-01-24 Lilly Co Eli Compounds
GB0030304D0 (en) * 2000-12-13 2001-01-24 Lilly Co Eli Compounds
GB0030306D0 (en) 2000-12-13 2001-01-24 Lilly Co Eli Compounds
GB0030303D0 (en) 2000-12-13 2001-01-24 Lilly Co Eli Compounds
TWI257389B (en) 2001-06-12 2006-07-01 Lilly Co Eli Pharmaceutical compound
US7265121B2 (en) * 2001-07-26 2007-09-04 Eli Lilly And Company Chemical compounds

Also Published As

Publication number Publication date
CA2478340A1 (en) 2003-10-16
UA76849C2 (uk) 2006-09-15
HRP20040900B1 (en) 2006-02-28
WO2003084929A1 (en) 2003-10-16
EA007300B1 (ru) 2006-08-25
BR0308870A (pt) 2005-01-04
PL373066A1 (en) 2005-08-08
DE60301569D1 (de) 2005-10-13
KR20040094892A (ko) 2004-11-10
EA200401290A1 (ru) 2005-02-24
ZA200407418B (en) 2005-09-15
DK1492767T3 (da) 2005-11-28
EP1492767A1 (en) 2005-01-05
ES2248737T3 (es) 2006-03-16
US7166606B2 (en) 2007-01-23
HK1070363A1 (en) 2005-06-17
CR7497A (es) 2005-01-17
JP2005531529A (ja) 2005-10-20
HRP20040900A2 (en) 2004-12-31
WO2003084929A8 (en) 2004-05-21
NZ535402A (en) 2006-02-24
ATE303990T1 (de) 2005-09-15
AU2003218147A1 (en) 2003-10-20
MXPA04009640A (es) 2005-01-11
NO20044688L (no) 2004-10-29
ECSP045329A (es) 2004-11-26
CN1288135C (zh) 2006-12-06
DE60301569T2 (de) 2006-06-14
EP1492767B1 (en) 2005-09-07
US20050096328A1 (en) 2005-05-05
CN1642914A (zh) 2005-07-20

Similar Documents

Publication Publication Date Title
IS2416B (is) Pýrrólídíndíónútskipt píperídín-þalasón sem PDE4 tálmar
IS6902A (is) N-setin heterósýklísk NMDA/NR2B mótlyf sem ekki eru arýl
IL164511A0 (en) Heterocyclic compounds
NO20061454L (no) Compounds having CRTH2 antagonist activity
MX2007000505A (es) Derivados de oxindol sustituidos y medicamentos que contienen los mismos.
MY136883A (en) 3-z-[1-(4-(n-((4-methyl-piperazin-1-yl)-methylcarbonyl)-n-methyl-amino)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone-monoethanesulphonate and the use thereof as a pharmaceutical composition
EA200600223A1 (ru) Замещённый 2-аминотетралины для лечения депрессии
MX2009002229A (es) Benzotriazoles como moduladores de cinasas.
PL362834A1 (en) Phenyl derivatives
NO20050828L (no) lndol-3-svovelderivater
DE602005012634D1 (en) Arylsulfonylnaphthalinderivate als 5ht2a-antagonisten
GB0314967D0 (en) Piperazine derivatives
NO20052182L (no) Nye forbindelser
NO20070089L (no) DPP-IV inhibitorer
TW200607805A (en) Novel pyridazinone derivatives, methods for producing them and their use as pharmaceuticals
DE602004018811D1 (de) Pyrrolidinylharnstoffderivate als angiogeneseinhibitoren
PL373066A1 (en) Certain 1-(d-cyclopropylglycinyl)-4-(piperidin-4-yl)piperazine compounds as inhibitors of the serine protease factor xa
MXPA03010205A (es) Derivados de acido oxalico.
MY137876A (en) Pharmaceutical compound
MXPA05006957A (es) Nuevos derivados de fosforamida.
WO2003076429A3 (en) Azepane derivatives and their use as atk1 inhibitors
DE60224805D1 (de) 1-glycinyl-4-(1-methylpiperidin-4-yl)piperazine un
PT1551827E (pt) Derivados de piperidina como inibidores de ccr5
TW200603806A (en) Pharmaceutical compound
SI1492767T1 (sl) Dolocene 1-(d-ciklopropilglicinil)-4-(piperidin-4-il)piperazinske spojine kot inhibitorji faktorja xa serinske proteaze